Publications

Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines.

JAMA
Cherla A, Wagner AK, Wouters OJ, Woloshin S, Davis C, Mossialos E, Naci H

New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019-22.

Health Aff (Millwood)
Cherla A, Woloshin S, Wagner AK, Wouters OJ, Davis C, Mossialos E, Naci H

A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations.

PLOS Digit Health
Srivastava D, Van Kessel R, Delgrange M, Cherla A, Sood H, Mossialos E

Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.

Lancet Oncol
Jenei K, Raymakers AJN, Bayle A, Berger-Thürmel K, Cherla A, Honda K, Jackson CCGA, Karikios D, Trapani D, Berry S, Gyawali B

Faster UK drug approvals by relying on other countries.

BMJ
Cherla A, Davis C, Mossialos E, Naci H

Post-Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004-2014.

Clin Pharmacol Ther
Cherla A, Mossialos E, Salcher-Konrad M, Kesselheim AS, Naci H

The 'Netflix plus model': can subscription financing improve access to medicines in low- and middle-income countries?

Health Econ Policy Law
Cherla A, Howard N, Mossialos E

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.

JAMA Intern Med
Cherla A, Naci H, Kesselheim AS, Gyawali B, Mossialos E

Improving transparency and performance of private hospitals.

BMJ
Anderson M, Cherla A, Wharton G, Mossialos E